当前位置:首页 - 行情中心 - 金域医学(603882) - 财务分析 - 现金流量表

金域医学

(603882)

  

流通市值:125.62亿  总市值:126.47亿
流通股本:4.60亿   总股本:4.63亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,319,687,996.996,803,247,136.154,812,327,401.643,066,685,526.72
  收到的税费返还809,257.6778,142,312.6380,133,379.0578,832,793.92
  收到其他与经营活动有关的现金34,251,770.2895,201,861.2481,225,288.3568,235,534.52
  经营活动现金流入小计1,354,749,024.946,976,591,310.024,973,686,069.043,213,753,855.16
  购买商品、接受劳务支付的现金621,278,110.893,055,942,868.352,177,622,945.441,393,331,272.69
  支付给职工以及为职工支付的现金442,127,689.531,731,876,059.391,243,528,966.87859,311,400.07
  支付的各项税费34,492,760.8157,847,532.42133,915,275.8110,819,907.06
  支付其他与经营活动有关的现金213,420,777.67828,915,582.76746,710,986.45499,821,783.89
  经营活动现金流出小计1,311,319,338.895,774,582,042.924,301,778,174.562,863,284,363.71
  经营活动产生的现金流量净额43,429,686.051,202,009,267.1671,907,894.48350,469,491.45
二、投资活动产生的现金流量:
  收回投资收到的现金208,078.1768,673,493.5260,786,632.3210,335,197.43
  取得投资收益收到的现金4,912,50011,130,355.57,473,000.811,725,775.88
  处置固定资产、无形资产和其他长期资产收回的现金净额1,650,982.2719,629,787.191,638,438.91,181,768.55
  投资活动现金流入小计6,771,560.4499,433,636.2169,898,072.0313,242,741.86
  购建固定资产、无形资产和其他长期资产支付的现金108,257,591.63423,455,734.18291,845,110.9174,236,937.49
  投资支付的现金34,843,534.5846,950,00040,833,333.3438,333,333.34
  投资活动现金流出小计143,101,126.21470,405,734.18332,678,444.24212,570,270.83
  投资活动产生的现金流量净额-136,329,565.77-370,972,097.97-262,780,372.21-199,327,528.97
三、筹资活动产生的现金流量:
  取得借款收到的现金15,908,533.58221,894,530.96113,745,121.5583,745,121.55
  筹资活动现金流入小计15,908,533.58221,894,530.96113,745,121.5583,745,121.55
  偿还债务支付的现金8,425,00087,494,887.7836,422,513.8929,997,513.89
  分配股利、利润或偿付利息支付的现金411,110,545.53434,136,325.29432,424,230.77426,807,753.62
  其中:子公司支付给少数股东的股利、利润-20,234,928.6914,200,00014,200,000
  支付其他与筹资活动有关的现金7,976,674.3894,466,022.0538,636,026.0828,298,735.92
  筹资活动现金流出小计427,512,219.91616,097,235.12507,482,770.74485,104,003.43
  筹资活动产生的现金流量净额-411,603,686.33-394,202,704.16-393,737,649.19-401,358,881.88
四、汇率变动对现金及现金等价物的影响11,117,107.32-13,551,197.53-6,458,287.49-7,028,422.73
五、现金及现金等价物净增加额-493,386,458.73423,283,267.448,931,585.59-257,245,342.13
  加:期初现金及现金等价物余额2,845,807,107.712,422,524,549.622,422,524,549.622,422,524,549.62
  期末现金及现金等价物余额2,352,420,648.982,845,807,817.062,431,456,135.212,165,279,207.49
补充资料:
  净利润--178,600,830.71--96,868,140.52
  资产减值准备-11,553,941.07--125,413.97
  固定资产和投资性房地产折旧-312,534,969.94-160,961,885.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-312,534,969.94-160,961,885.9
  无形资产摊销-14,504,323.5-6,408,546.82
  长期待摊费用摊销-88,259,297.34-44,551,120.84
  处置固定资产、无形资产和其他长期资产的损失--4,398,060.89--2,441,961.14
  固定资产报废损失-2,482,860.79-439,518.91
  公允价值变动损失-2,124,860.34--
  财务费用-14,678,676.91-8,006,679.54
  投资损失--3,838,869.54--2,008,308.27
  递延所得税--76,438,932.93--48,843,708.63
  其中:递延所得税资产减少--68,578,384.01--45,647,654.21
    递延所得税负债增加--7,860,548.92--3,196,054.42
  存货的减少-12,212,396.4-7,591,803.02
  经营性应收项目的减少-742,598,880.05-78,365,080.54
  经营性应付项目的增加--193,553,038.26--151,710,293.42
  其他---28,298,735.92
  现金的期末余额-2,845,807,817.06-2,165,279,207.49
  减:现金的期初余额-2,422,524,549.62-2,422,524,549.62
  现金及现金等价物的净增加额-423,283,267.44--257,245,342.13
公告日期2026-04-252026-04-252025-10-302025-08-23
审计意见(境内)标准无保留意见
TOP↑